Sanara MedTech Secures $55 Million Term Loan with Strategic Conditions
Company Announcements

Sanara MedTech Secures $55 Million Term Loan with Strategic Conditions

Sanara MedTech (SMTI) has provided an update.

Sanara MedTech Inc. secured a $55 million senior secured term loan with initial borrowing set at $15 million and additional access to funds under specific conditions. The loan, maturing on March 30, 2029, carries an interest rate of 13.25%, payable quarterly, and will be used for various corporate purposes, including repayment of the previous Cadence Term Loan. Prepayment premiums apply under certain conditions, and the company’s assets are collateralized. The agreement also imposes financial covenants and operational restrictions to maintain the company’s fiscal discipline.

Learn more about SMTI stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSanara MedTech Expands Portfolio with ChemoMouthpiece Investment
TheFlySanara MedTech and InfuSystem execute U.S. distribution agreement
GlobeNewswireSanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App